Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues

A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virologic response to lamivudine

(2012) Jeong Heo et al.   ANTIVIRAL THERAPY

Treatment of chronic hepatitis B: Update of the recommendations from the 2007 Italian Workshop

(2011) Giampiero Carosi et al.   DIGESTIVE AND LIVER DISEASE

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

(2011) G. V. Papatheodoridis et al.   GUT

Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B

(2010) G. L.-H. Wong et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

(2009) Florian van Bömmel et al.   HEPATOLOGY

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

(2009) Yun-Fan Liaw   LIVER INTERNATIONAL

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

(2008) Patrick Marcellin et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

(2007) Giovanna Fattovich et al.   JOURNAL OF HEPATOLOGY